Scinai Immunotherapeutics
Maxim Leykin has a diverse work experience in engineering and management roles. Maxim currently serves as the Head of Engineering at Scinai Immunotherapeutics Ltd. since September 2022. Prior to that, they worked as a Process Utility Engineer at Omrix Biopharmaceuticals from May 2017 to September 2022. Maxim also worked as an Engineer at LUDAN Engineering Co. Ltd. from June 2015 to May 2017. In addition, Maxim has previous experience as a Critical System ENG at Omrix Biopharmaceuticals from February 2014 to November 2014, a Maintenance Manager at SodaStream International, Ltd. from February 2013 to February 2014, an Equipment Maintenance Eng at Micron Technology from February 2008 to February 2013, and a Senior Service Technician at Intel Corporation from 1999 to February 2007.
Maxim Leykin attended Afeka Tel-Aviv Academic College of Engineering from 2004 to 2010, where they obtained a Bachelor of Science degree in Mechanical and Systems Engineering.
This person is not in any offices
Scinai Immunotherapeutics
1 followers
Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI) is a biopharmaceutical company focused on developing, manufacturing, and commercializing innovative inflammation and immunology (I&I) biological products primarily for the treatment of autoimmune and infectious diseases. With a state-of-the-art facility for biopharmaceutical product development and manufacturing and highly experienced pharmaceutical industry leadership, Scinai offers end-to-end boutique CDMO services in parallel to developing its own pipeline of diversified and commercially viable products and platforms beginning with an innovative nanosized VHH antibody (NanoAb) pipeline targeting diseases with large unmet medical needs. Company website: www.scinai.com